Industry

Bharat Biotech commences direct supply of COVID-19 vaccine Covaxin to 14 States

On April 29, Bharat Biotech announced a cut in the price of 'Covaxin' for States to ₹400 per dose from the earlier ₹600 per dose. File   | Photo Credit: B. Jothi Ramalingam

Bharat Biotech has commenced direct supply of its COVID-19 vaccine ‘Covaxin’ to 14 States, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director Suchitra Ella.

The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the States based on the allocations received by the Central government.

“Bharat Biotech confirms direct supplies of COVAXIN to the following State govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other States, & will be processed for distribution based on availability of stocks 24x7,” Ms. Ella tweeted.

The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.

On April 29, Bharat Biotech announced a cut in the price of ‘Covaxin’ for States to ₹400 per dose from the earlier ₹600 per dose.

This followed widespread criticism of its pricing policy as it sold Covaxin to the Central government at ₹150 per dose.

India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jun 18, 2021 5:54:01 AM | https://www.thehindu.com/business/Industry/bharat-biotech-commences-direct-supply-of-covid-19-vaccine-covaxin-to-14-states/article34525177.ece

Next Story